Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas-Antonios Roussakis

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
International Review of Neurobiology|October 14, 2018
Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's DiseaseAndreas-Antonios Roussakis, Paola Piccini
Journal of Huntington'S Disease|December 20, 2015
PET Imaging in Huntington's DiseaseAndreas-Antonios Roussakis, Paola Piccini
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian SyndromesAndreas-Antonios Roussakis, Paola Piccini, Marios Politis
Journal of Neurology|January 15, 2025
Benefits of a 12-week psychotherapy course for people with Parkinson's disease: a service improvement projectAndreas-Antonios Roussakis, Rima Hawkins, Cara Mackley, et al.
Current Neurology and Neuroscience Reports|August 10, 2019
Brain Imaging and Impulse Control Disorders in Parkinson's DiseaseAndreas-Antonios Roussakis, Nicholas P Lao-Kaim, Paola Piccini
Neurology|February 28, 2016
Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesiasAndreas-Antonios Roussakis, Marios Politis, David Towey, et al.
Parkinsonism & Related Disorders|August 30, 2020
Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's diseaseEleanor Porter, Andreas-Antonios Roussakis, Nicholas P Lao-Kaim, et al.
Neurobiology of Aging|September 9, 2020
Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probesZhou Zeng, Andreas-Antonios Roussakis, Nicholas P Lao-Kaim, et al.
Journal of Neuroinflammation and Neurodegenerative Diseases|December 11, 2019
Dopamine Transporter Density in <i>de novo</i> Parkinson's Disease Does Not Relate to the Development of Levodopa-Induced DyskinesiasAndreas-Antonios Roussakis, Marta Gennaro, Nicholas P Lao-Kaim, et al.
Journal of Neurology|September 4, 2020
Parkinson's disease laterality: a <sup>11</sup>C-PE2I PET imaging studyAndreas-Antonios Roussakis, Zhou Zeng, Nicholas P Lao-Kaim, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
International Review of Neurobiology|October 14, 2018
Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's DiseaseAndreas-Antonios Roussakis, Paola Piccini
Journal of Huntington'S Disease|December 20, 2015
PET Imaging in Huntington's DiseaseAndreas-Antonios Roussakis, Paola Piccini
Degenerative Neurological and Neuromuscular Disease|March 21, 2019
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian SyndromesAndreas-Antonios Roussakis, Paola Piccini, Marios Politis
Journal of Neurology|January 15, 2025
Benefits of a 12-week psychotherapy course for people with Parkinson's disease: a service improvement projectAndreas-Antonios Roussakis, Rima Hawkins, Cara Mackley, et al.
Current Neurology and Neuroscience Reports|August 10, 2019
Brain Imaging and Impulse Control Disorders in Parkinson's DiseaseAndreas-Antonios Roussakis, Nicholas P Lao-Kaim, Paola Piccini
Neurology|February 28, 2016
Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesiasAndreas-Antonios Roussakis, Marios Politis, David Towey, et al.
Parkinsonism & Related Disorders|August 30, 2020
Multimodal dopamine transporter (DAT) imaging and magnetic resonance imaging (MRI) to characterise early Parkinson's diseaseEleanor Porter, Andreas-Antonios Roussakis, Nicholas P Lao-Kaim, et al.
Neurobiology of Aging|September 9, 2020
Astrocytes in Parkinson's disease: from preclinical assays to in vivo imaging and therapeutic probesZhou Zeng, Andreas-Antonios Roussakis, Nicholas P Lao-Kaim, et al.
Journal of Neuroinflammation and Neurodegenerative Diseases|December 11, 2019
Dopamine Transporter Density in <i>de novo</i> Parkinson's Disease Does Not Relate to the Development of Levodopa-Induced DyskinesiasAndreas-Antonios Roussakis, Marta Gennaro, Nicholas P Lao-Kaim, et al.
Journal of Neurology|September 4, 2020
Parkinson's disease laterality: a <sup>11</sup>C-PE2I PET imaging studyAndreas-Antonios Roussakis, Zhou Zeng, Nicholas P Lao-Kaim, et al.
Pageof 2